You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

PRISMASOL B22GK 4 Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

When do Prismasol B22gk 4 patents expire, and when can generic versions of Prismasol B22gk 4 launch?

Prismasol B22gk 4 is a drug marketed by Vantive Us Hlthcare and is included in one NDA.

The generic ingredient in PRISMASOL B22GK 4 is calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride. There are two hundred and eighty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for PRISMASOL B22GK 4?
What are the global sales for PRISMASOL B22GK 4?
What is Average Wholesale Price for PRISMASOL B22GK 4?

Summary for PRISMASOL B22GK 4

US Patents:	0
Applicants:	1
NDAs:	1
DailyMed Link:	PRISMASOL B22GK 4 at DailyMed

Drug patent expirations by year for PRISMASOL B22GK 4

US Patents and Regulatory Information for PRISMASOL B22GK 4

+ Get email alerts for changes to this table

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Vantive Us Hlthcare	PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER	calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride	INJECTABLE;INJECTION	021703-011	Oct 10, 2008		RX	Yes	Yes	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
Vantive Us Hlthcare	PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER	calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride	INJECTABLE;INJECTION	021703-013	Oct 10, 2008		DISCN	Yes	No	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.